Pure leaf kratom batches should not compete with extracts

Red, green, white, yellow, and blend labels do not establish whether a product is unmodified leaf. Krate.one classifies from the product form, vendor source, ingredient or enhancement language, and available evidence. If the source is unclear, the record remains unknown.

The default board prioritizes pure leaf because that is where batch-to-batch agricultural variation is most useful to compare. Enhanced products and extracts can still be tracked, but their concentrations should not reset the scale for ordinary powder.

Classification reflects collected vendor sources as of September 2, 2026; it is not independent laboratory authentication.

A product may be clearly labeled as extract or enhanced, or it may use marketing language that requires a closer look at the form and alkaloid context. Krate.one does not use a single number as automatic proof of modification. The record should preserve what the source says and flag uncertainty for review.

Separating classes protects the usefulness of MIT comparisons. It also prevents a buyer searching for ordinary leaf from landing on tablets, shots, isolates, or fortified blends simply because their reported concentration is higher.

Product class and proof status answer different questions. A product can be plausibly pure leaf while its current batch number, COA, or lab date remains unknown. Conversely, a well-documented extract can have strong evidence while belonging outside the pure-leaf ranking.

Krate.one keeps both dimensions visible. The best research record states the class, source, exact lot, lab scope, and current availability without letting one field substitute for another.

For a plain-leaf comparison, narrow to the same product class and then inspect the exact-lot match, dates, MIT, 7-OH, evidence source, and activity. A current vendor claim and an exact laboratory report can appear together, but their confidence labels should remain different.

Krate.one does not use these fields to make medical, effects, or dosage recommendations. They are product-transparency fields for adults researching current marketplace inventory.